156 related articles for article (PubMed ID: 22854134)
1. Predicting the histology of small renal masses using preoperative dynamic contrast-enhanced magnetic resonance imaging.
Kim JH; Bae JH; Lee KW; Kim ME; Park SJ; Park JY
Urology; 2012 Oct; 80(4):872-6. PubMed ID: 22854134
[TBL] [Abstract][Full Text] [Related]
2. Commentary on "Predicting the histology of small renal masses using preoperative dynamic contrast-enhanced magnetic resonance imaging." Kim JH, Bae JH, Lee KW, Kim ME, Park SJ, Park JY, Department of Urology, Soonchunhyang University Hospital, Seoul, Korea.
Meng MV
Urol Oncol; 2013 Jan; 31(1):133-4. PubMed ID: 23419730
[TBL] [Abstract][Full Text] [Related]
3. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings.
Sun MR; Ngo L; Genega EM; Atkins MB; Finn ME; Rofsky NM; Pedrosa I
Radiology; 2009 Mar; 250(3):793-802. PubMed ID: 19244046
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of diffusion-weighted imaging in the evaluation of renal masses.
Sandrasegaran K; Sundaram CP; Ramaswamy R; Akisik FM; Rydberg MP; Lin C; Aisen AM
AJR Am J Roentgenol; 2010 Feb; 194(2):438-45. PubMed ID: 20093607
[TBL] [Abstract][Full Text] [Related]
5. [MR imaging features of different renal cell carcinoma subtypes].
Wu B; Peng WJ; Gu YJ; Yang TX; Jiang ZX; Zhang HL; Dai B; Ye DW; Kong YY; Du X
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):825-30. PubMed ID: 19173827
[TBL] [Abstract][Full Text] [Related]
6. Combined late gadolinium-enhanced and double-echo chemical-shift MRI help to differentiate renal oncocytomas with high central T2 signal intensity from renal cell carcinomas.
Cornelis F; Lasserre AS; Tourdias T; Deminière C; Ferrière JM; Le Bras Y; Grenier N
AJR Am J Roentgenol; 2013 Apr; 200(4):830-8. PubMed ID: 23521457
[TBL] [Abstract][Full Text] [Related]
7. Differential diagnosis of complex cystic renal mass using multiphase computerized tomography.
Song C; Min GE; Song K; Kim JK; Hong B; Kim CS; Ahn H
J Urol; 2009 Jun; 181(6):2446-50. PubMed ID: 19375094
[TBL] [Abstract][Full Text] [Related]
8. Histogram analysis of whole-lesion enhancement in differentiating clear cell from papillary subtype of renal cell cancer.
Chandarana H; Rosenkrantz AB; Mussi TC; Kim S; Ahmad AA; Raj SD; McMenamy J; Melamed J; Babb JS; Kiefer B; Kiraly AP
Radiology; 2012 Dec; 265(3):790-8. PubMed ID: 23175544
[TBL] [Abstract][Full Text] [Related]
9. Small renal masses: assessment of lesion characterization and vascularity on dynamic contrast-enhanced MR imaging with fat suppression.
Scialpi M; Di Maggio A; Midiri M; Loperfido A; Angelelli G; Rotondo A
AJR Am J Roentgenol; 2000 Sep; 175(3):751-7. PubMed ID: 10954462
[TBL] [Abstract][Full Text] [Related]
10. Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade.
Rosenkrantz AB; Niver BE; Fitzgerald EF; Babb JS; Chandarana H; Melamed J
AJR Am J Roentgenol; 2010 Nov; 195(5):W344-51. PubMed ID: 20966299
[TBL] [Abstract][Full Text] [Related]
11. Dynamic contrast-enhanced magnetic resonance imaging assessment of kidney function and renal masses: single slice versus whole organ/tumor.
Winter KS; Helck AD; Ingrisch M; Staehler M; Stief C; Sommer WH; Braunagel M; Kazmierczak PM; Reiser MF; Nikolaou K; Notohamiprodjo M
Invest Radiol; 2014 Nov; 49(11):720-7. PubMed ID: 24901546
[TBL] [Abstract][Full Text] [Related]
12. Predictive Value of Chemical-Shift MRI in Distinguishing Clear Cell Renal Cell Carcinoma From Non-Clear Cell Renal Cell Carcinoma and Minimal-Fat Angiomyolipoma.
Jhaveri KS; Elmi A; Hosseini-Nik H; Hedgire S; Evans A; Jewett M; Harisinghani M
AJR Am J Roentgenol; 2015 Jul; 205(1):W79-86. PubMed ID: 26102422
[TBL] [Abstract][Full Text] [Related]
13. Investigation of renal lesions by diffusion-weighted magnetic resonance imaging applying intravoxel incoherent motion-derived parameters--initial experience.
Rheinheimer S; Stieltjes B; Schneider F; Simon D; Pahernik S; Kauczor HU; Hallscheidt P
Eur J Radiol; 2012 Mar; 81(3):e310-6. PubMed ID: 22104090
[TBL] [Abstract][Full Text] [Related]
14. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
[TBL] [Abstract][Full Text] [Related]
15. Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype.
Goyal A; Sharma R; Bhalla AS; Gamanagatti S; Seth A; Iyer VK; Das P
Acta Radiol; 2012 Apr; 53(3):349-58. PubMed ID: 22496427
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging as a biomarker in renal cell carcinoma.
Pedrosa I; Alsop DC; Rofsky NM
Cancer; 2009 May; 115(10 Suppl):2334-45. PubMed ID: 19402070
[TBL] [Abstract][Full Text] [Related]
17. Value of T2-weighted MR imaging in differentiating low-fat renal angiomyolipomas from other renal tumors.
Choi HJ; Kim JK; Ahn H; Kim CS; Kim MH; Cho KS
Acta Radiol; 2011 Apr; 52(3):349-53. PubMed ID: 21498374
[TBL] [Abstract][Full Text] [Related]
18. Imaging characteristics of papillary renal cell carcinoma by computed tomography scan and magnetic resonance imaging.
Tsuda K; Kinouchi T; Tanikawa G; Yasuhara Y; Yanagawa M; Kakimoto K; Ono Y; Meguro N; Maeda O; Arisawa J; Usami M
Int J Urol; 2005 Sep; 12(9):795-800. PubMed ID: 16201974
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic value of mult-detector CT for papillary renal cell carcinoma and chromophobe renal cell carcinoma].
Liu X; Zou X; Chen H; Fang X; Hu X; Sun R
Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):52-6. PubMed ID: 25877320
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Contrast-Enhanced Multiphase Renal Protocol CT Versus MRI for Diagnosis of Papillary Renal Cell Carcinoma.
Dilauro M; Quon M; McInnes MD; Vakili M; Chung A; Flood TA; Schieda N
AJR Am J Roentgenol; 2016 Feb; 206(2):319-25. PubMed ID: 26797358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
